BNTX
BioNTechยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BNTX Profile
Biontech Se
A company that develops personalized immunotherapies for the treatment of cancer
Biological Technology
06/02/2008
10/10/2019
NASDAQ Stock Exchange
6,772
12-31
Depository Receipts (Ordinary Shares)
An der Goldgrube 12, D-55131 Mainz, Germany
--
BioNTech SE was established on June 2, 2008. The company combines decades of pioneering research in immunology, cutting-edge therapeutic platforms, and various patient analysis and bioinformatics tools to develop individualized immunotherapies for cancer and other diseases. The company utilizes powerful new therapeutic mechanisms, utilizes a variety of biological targets, harnesses the power of each patient's immune system, and addresses the unique molecular characteristics of each patient's underlying disease.
